Akoya Biosciences, Inc. 4 SEC Filings

Filed On	Filing
10 Jul 2025	Form 4: Mendel Scott, Director Disposed of 28,500 shares (Other Transaction) · Disposed of 217,392 Stock Option (right to buy) (Other Transaction)
10 Jul 2025	Form 4: Ramachandran Niro Ph.D, Chief Business Officer Acquired 62,566 shares (Other Transaction) · Gave up 42,148 shares to cover exercise price or tax · Disposed of 282,555 shares (Other Transaction) · 2 more
10 Jul 2025	Form 4: McKelligon Brian, Director Acquired 724,428 shares (Other Transaction) · Gave up 196,866 shares to cover exercise price or tax · Disposed of 947,688 shares (Other Transaction) · 1 more
10 Jul 2025	Form 4: Kamocsay Jennifer, Chief Legal Officer Disposed of 179,272 shares (Other Transaction) · Disposed of 145,000 Employee Stock Option (Right to Buy) (Other Transaction)
10 Jul 2025	Form 4: Ek John Frederick, CFO Disposed of 268,202 shares (Other Transaction) · Disposed of 230,000 Employee Stock Option (Right to Buy) (Other Transaction)
10 Jul 2025	Form 4: Bamford Pascal, Chief Clinical Officer Disposed of 205,738 shares (Other Transaction) · Disposed of 240,000 Employee Stock Option (Right to Buy) (Other Transaction)
10 Jul 2025	Form 4: Winkler Matthew, Director Disposed of 984,513 shares (Other Transaction) · Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)
10 Jul 2025	Form 4: Shepler Robert G, Director Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)
10 Jul 2025	Form 4: Schnettler Thomas P, Director Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)
10 Jul 2025	Form 4: Raffin Thomas A., Director Disposed of 17,909,839 shares (Other Transaction) · Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)
10 Jul 2025	Form 4: Lai Goldman Myla, Director Disposed of 20,000 shares (Other Transaction) · Disposed of 38,993 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)
02 Jun 2025	Form 4: Bamford Pascal, Chief Clinical Officer Gave up 670 shares to cover exercise price or tax ($838)
03 Apr 2025	Form 4: Ek John Frederick, CFO Gave up 16,432 shares to cover exercise price or tax ($22.2K)
25 Mar 2025	Form 4: McKelligon Brian, Director Gave up 7,550 shares to cover exercise price or tax ($12.8K)
25 Mar 2025	Form 4: Ramachandran Niro Ph.D, Chief Business Officer Gave up 2,310 shares to cover exercise price or tax ($3.93K)
04 Mar 2025	Form 4: Kamocsay Jennifer, Chief Legal Officer Gave up 7,445 shares to cover exercise price or tax ($12.1K)
04 Mar 2025	Form 4: Ek John Frederick, CFO Gave up 3,594 shares to cover exercise price or tax ($5.86K)
04 Mar 2025	Form 4: Bamford Pascal, Chief Clinical Officer Gave up 3,850 shares to cover exercise price or tax ($6.28K)
04 Mar 2025	Form 4: Ramachandran Niro Ph.D, Chief Business Officer Gave up 5,904 shares to cover exercise price or tax ($9.62K)
04 Mar 2025	Form 4: McKelligon Brian, Director Gave up 15,807 shares to cover exercise price or tax ($25.8K)

Comments